Literature DB >> 9834463

Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation.

D E Clark1, S K Smith, D Licence, A L Evans, D S Charnock-Jones.   

Abstract

Angiogenesis and vascular transformation are important processes in the normal development of the placenta. Vascular endothelial growth factor (VEGF) is a potent angiogenic growth factor and is thought to be important for placental development. Recently several new members of this family have been described. In this study we used in situ hybridisation to localise which cells in the placenta expressed mRNA for VEGF, placenta growth factor (PlGF), VEGF-B and VEGF-C. We were unable to find any message for either VEGF-B or VEGF-C in the placenta, suggesting that only low levels are produced which this method was unable to detect. The mRNA encoding VEGF was found to be produced by cells within the villous mesenchyme, decidual macrophages and decidual glands but, in contrast to our previous findings, not by trophoblast. The mRNA encoding PlGF was produced in large amounts by villous cytotrophoblast, syncytiotrophoblast and extravillous trophoblast. The mRNAs encoding VEGF and PlGF were thus not co-localised and it appears that there is unlikely to be any significant production of VEGF/PlGF heterodimer in the placenta.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9834463     DOI: 10.1677/joe.0.1590459

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  25 in total

Review 1.  First trimester serum markers to predict preeclampsia.

Authors:  Berthold Huppertz; Rie Kawaguchi
Journal:  Wien Med Wochenschr       Date:  2012-05

Review 2.  Intravenous immunoglobulin and recurrent pregnancy loss.

Authors:  Howard J A Carp; Tal Sapir; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

Review 3.  Explant culture: An advantageous method for isolation of mesenchymal stem cells from human tissues.

Authors:  Fatemeh Hendijani
Journal:  Cell Prolif       Date:  2017-02-01       Impact factor: 6.831

Review 4.  Angiogenic factors in preeclampsia and related disorders.

Authors:  Ana Sofia Cerdeira; S Ananth Karumanchi
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

Review 5.  Innate immunity, decidual cells, and preeclampsia.

Authors:  Chang-Ching Yeh; Kuan-Chong Chao; S Joseph Huang
Journal:  Reprod Sci       Date:  2012-07-18       Impact factor: 3.060

6.  Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface.

Authors:  Satyan S Kalkunte; Teddy F Mselle; Wendy E Norris; Charles R Wira; Charles L Sentman; Surendra Sharma
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

7.  Human pregnancy specific beta-1-glycoprotein 1 (PSG1) has a potential role in placental vascular morphogenesis.

Authors:  Cam T Ha; Julie A Wu; Ster Irmak; Felipe A Lisboa; Anne M Dizon; James W Warren; Suleyman Ergun; Gabriela S Dveksler
Journal:  Biol Reprod       Date:  2010-03-24       Impact factor: 4.285

8.  Differential regulation of human PlGF gene expression in trophoblast and nontrophoblast cells by oxygen tension.

Authors:  R M Gobble; K A Groesch; M Chang; R J Torry; D S Torry
Journal:  Placenta       Date:  2009-08-26       Impact factor: 3.481

9.  Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?

Authors:  L Myatt; R G Clifton; J M Roberts; C Y Spong; R J Wapner; J M Thorp; B M Mercer; A M Peaceman; S M Ramin; M W Carpenter; A Sciscione; J E Tolosa; G Saade; Y Sorokin; G D Anderson
Journal:  BJOG       Date:  2013-01-18       Impact factor: 6.531

Review 10.  Potential markers of preeclampsia--a review.

Authors:  Simon Grill; Corinne Rusterholz; Rosanna Zanetti-Dällenbach; Sevgi Tercanli; Wolfgang Holzgreve; Sinuhe Hahn; Olav Lapaire
Journal:  Reprod Biol Endocrinol       Date:  2009-07-14       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.